ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,523.79
      1.04%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Galectin Therapeutics Inc (GALT)

      7. Galectin Therapeutics Inc (GALT) News

      GALT

      Galectin Therapeutics (GALT)

      Galectin Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GALT
      DateTimeSourceHeadlineSymbolCompany
      09/10/20208:00AMGlobeNewswire Inc.Galectin Therapeutics Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020NASDAQ:GALTGalectin Therapeutics Inc
      09/09/20208:01AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      09/09/20208:00AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      09/02/20209:01AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      09/02/20208:00AMGlobeNewswire Inc.Galectin Therapeutics Appoints Joel Lewis as Chief Executive OfficerNASDAQ:GALTGalectin Therapeutics Inc
      09/02/20207:52AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GALTGalectin Therapeutics Inc
      08/10/20208:00AMGlobeNewswire Inc.Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2020, and Provides Business UpdateNASDAQ:GALTGalectin Therapeutics Inc
      08/10/20207:56AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GALTGalectin Therapeutics Inc
      08/10/20207:52AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GALTGalectin Therapeutics Inc
      06/30/20209:05AMGlobeNewswire Inc.UPDATE -- Galectin Therapeutics Announces Commencement of Patient Enrollment of the Adaptively-Designed Phase 2b/3 Trial of B...NASDAQ:GALTGalectin Therapeutics Inc
      06/30/20208:00AMGlobeNewswire Inc.Galectin Therapeutics Announces Commencement of Patient Enrollment of the Adaptively-Designed Phase 2b/3 Trial of Belapectin ...NASDAQ:GALTGalectin Therapeutics Inc
      06/30/20207:59AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GALTGalectin Therapeutics Inc
      06/26/20204:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GALTGalectin Therapeutics Inc
      05/22/20206:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GALTGalectin Therapeutics Inc
      05/11/20208:00AMGlobeNewswire Inc.Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2020, and Provides Business UpdateNASDAQ:GALTGalectin Therapeutics Inc
      05/11/20207:49AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GALTGalectin Therapeutics Inc
      05/11/20207:47AMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:GALTGalectin Therapeutics Inc
      05/11/20206:32AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GALTGalectin Therapeutics Inc
      04/30/20209:00AMGlobeNewswire Inc.Galectin Therapeutics Submits Seamless Adaptively-Designed Phase 2b/3 NASH-RX Protocol in NASH CirrhosisNASDAQ:GALTGalectin Therapeutics Inc
      04/30/20208:56AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GALTGalectin Therapeutics Inc
      04/02/20208:04AMGlobeNewswire Inc.Galectin Therapeutics Update on the Impact of COVID-19NASDAQ:GALTGalectin Therapeutics Inc
      03/20/20208:31AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      03/17/20208:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GALTGalectin Therapeutics Inc
      03/16/20204:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      03/16/20204:31PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GALTGalectin Therapeutics Inc
      03/16/20208:00AMGlobeNewswire Inc.Galectin Therapeutics Reports Fiscal 2019 Financial Results and Provides Business UpdateNASDAQ:GALTGalectin Therapeutics Inc
      02/20/20208:00AMGlobeNewswire Inc.Galectin Therapeutics Appoints Seasoned Biopharmaceutical Executive Pol F. Boudes, M.D. as Chief Medical OfficerNASDAQ:GALTGalectin Therapeutics Inc
      02/20/20207:55AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GALTGalectin Therapeutics Inc
      02/14/20208:01AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GALTGalectin Therapeutics Inc
      02/13/20205:00PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:GALTGalectin Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:GALT